AJMC - The American Journal of Managed Care’s Post

Another publication highlighting the importance of collecting medical data from Health Records, process to collect data with high quality is crucial. Attached some examples in cancer. #RWD #clinicalresearch #RWE

Our latest systematic review article titled "Quality of Life Among Patients with Cancer in India: A Systematic Review" published in National Journal of Community Medicine. Read the full article here: https://lnkd.in/gGwT84nV #CancerResearch #QualityOfLife #SystematicReview #WHOQOL #HealthcareResearch #CancerCare

This comprehensive analysis of our program to provide high impact medicines for Gastrointestinal Stromal Tumors gives hope to people in need of treatment in low- and middle-income countries (LMICs) 🌍 Accessing life-saving treatments resulted in a median overall survival of 5.8 years for metastatic or unresectable disease, and a 73.8% 10-year survival rate in the adjuvant setting 📊 This marks a significant stride in cancer care, proving that with the right support, physicians in LMICs can achieve outcomes comparable to high-resource countries. 🌟 Edward Briercheck J. Michael Wrigglesworth Inés García González Cathy Scheepers Viji Venkatesh Alicia Annamalay Pat Garcia-Gonzalez Michael Wagner JAMA Network Open #CancerCare #GlobalHealth #TheMaxFoundation

COTA and Texas Oncology’s Precision Health Informatics, LLC collaborate to use #AI in transforming healthcare data into actionable insights, enhancing #precisionmedicine and #cancer care. Read at The Evidence Base® #rwe #rwd #realworldevidence #realworlddata #healthdata #electronichealthrecords #EHRs #oncology #artificialintelligence

Unlocking the potential of personalized cancer treatment is crucial in improving patient outcomes. Our approach at Rejuve.Bio mirrors this, harnessing AI to tailor interventions for individual health needs, paving the way for precision medicine advancements. Learn more about Rejuve.Bio and our crowdfund here bit.ly/rjvbcrowdfund https://lnkd.in/ggPQGiis

❓ How can implementation science #impsci frameworks help implement electronic patient-reported outcome (ePRO) symptom monitoring in routine cancer care? Check out our study using the Consolidated Framework for Implementation Research (CFIR) published today @JCOOP_ASCO 🌟 Novel barriers + facilitators identified 📝 Theory-informed #impsci strategies generated for key steps in the ePRO symptom monitoring process Full paper: https://lnkd.in/gTguzYJj

𝑩𝒍𝒐𝒐𝒅 𝑻𝒆𝒔𝒕𝒔: 𝑷𝒂𝒗𝒊𝒏𝒈 𝒕𝒉𝒆 𝑾𝒂𝒚 𝒇𝒐𝒓 𝑬𝒂𝒓𝒍𝒚 𝑫𝒊𝒔𝒆𝒂𝒔𝒆 𝑫𝒆𝒕𝒆𝒄𝒕𝒊𝒐𝒏 𝒂𝒏𝒅 𝑻𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎𝒊𝒏𝒈 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆 𝑫𝒊𝒂𝒈𝒏𝒐𝒔𝒕𝒊𝒄𝒔 Blood tests are rapidly changing the landscape of disease diagnosis. This year, the FDA approved two blood tests for colon cancer, a new test was developed for Alzheimer’s diagnosis, and a test was shown to predict cardiovascular events in women up to 30 years in advance. 🧬 🩸 With health systems and private companies exploring these developments, blood tests are opening new doors for earlier and more accurate detection. While there’s still some debate, especially around cancer screening accuracy, the potential is undeniable. #BloodTests #Diagnostics #CardiovascularHealth #CancerScreening #LifeSciences

Really great article here. There's a ton of potential from advancements in liquid biopsy technology for cancer care. Early detection and treatment are key to cancer survival, and that's an area it's proving highly successful in. But Gebra Cuyun Carter and Caitlin Kubler point out a disappointing fact: "Research is already showing that liquid biopsy for selecting treatment is falling into well-established patterns of use." As we move towards integrating liquid biopsy into standard care, addressing these disparities is key to ensuring that innovations like this benefit all patients equitably. Collaboration among stakeholders will be essential to mitigate these risks and promote fair access across diverse populations. #PrecisionMedicine #Healthcare #HealthEquity

In the latest issue of the Journal of Clinical Pathways, Poka Cui, Peter Blanshard, María Teresa Campos, Adrien Moucquot, S. Hassan N., David Dellamonica, and Heather Moses completed a literature review along with interviews involving lung cancer multidisciplinary teams (MDTMs) from 24 medical centers across Europe and Canada to identify best practices and develop a self-assessment toolkit for MDTMs. "The report discusses how these results should be used to self-optimize hospital MDTs, promote standardization, and encourage increased cross-hospital best practices sharing. With this, MDTs will be better positioned to deliver on the key goal of improved patient outcomes while promoting equality of access to health care," said the authors. Read the full report here: https://lnkd.in/g5jz8Mdk #JournalOfClinicalPathways #ValueBasedCare #StandardOfCare #CancerCare #LungCancer #MultidisciplinaryTeams #BestPractices #ResearchReports

Excited to share the article below, for which I’m a co-author, together with María Teresa Campos, Adrien Moucquot, David Dellamonica and Heather Moses     Based on research conducted with 24 hospitals across Europe and Canada, as part of our MDT Aid Program (MAP), this article sets out the key areas in which process variation is seen in Multi-Disciplinary Teams (MDTs) working in cancer, as well as a framework and approach to address and reduce this variability.    I’m really pleased that AstraZeneca is supporting this work. Effective MDTs can make a critical difference in determining the right treatment approach for a person with cancer. Any variability in this effectiveness can have a knock-on impact on patient outcomes, and so it’s only right that we do what we can to support improvements across the board.  Many thanks to the MDTs and hospitals who contributed to the research. Please check out the paper below! https://lnkd.in/eNiihgFT